These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 30972789)
1. Seroprevalence of human T-lymphotropic virus (HTLV) in blood donors in sub-Saharan Africa: a systematic review and meta-analysis. Ngoma AM; Omokoko MD; Mutombo PB; Nollet KE; Ohto H Vox Sang; 2019 Jul; 114(5):413-425. PubMed ID: 30972789 [TBL] [Abstract][Full Text] [Related]
2. Population-based prevalence of human T-lymphotropic virus type 1 in sub-Saharan Africa: a systematic review and meta-analysis. Ngoma AM; Omokoko MD; Mutombo PB; Mvika ES; Muwonga JM; Nollet KE; Ohto H Trop Med Int Health; 2019 Nov; 24(11):1277-1290. PubMed ID: 31465629 [TBL] [Abstract][Full Text] [Related]
3. The prevalence of human T-lymphotropic virus type 1 & 2 (HTLV-1/2) in South African blood donors. Vermeulen M; Sykes W; Coleman C; Custer B; Jacobs G; Jaza J; Kaidarova Z; Hlela C; Gessain A; Cassar O; Poole C; Ingram C; Murphy EL; Reddy R Vox Sang; 2019 Jul; 114(5):451-458. PubMed ID: 30950074 [TBL] [Abstract][Full Text] [Related]
4. Prevalence and Molecular Epidemiology of Human T-Lymphotropic Virus Type 1 among Women Attending Antenatal Clinics in Sub-Saharan Africa: A Systematic Review and Meta-Analysis. Ngoma AM; Mutombo PB; Omokoko MD; Mvika ES; Nollet KE; Ohto H Am J Trop Med Hyg; 2019 Oct; 101(4):908-915. PubMed ID: 31407658 [TBL] [Abstract][Full Text] [Related]
5. [Investigation of anti-HTLV I/II seroprevalence in healthy blood donors in Izmir region, Turkey]. Sertöz R; Turhan A; Bozkurt H; Samlıoğlu P; Değirmenci A; Aydınok Y; Erensoy S Mikrobiyol Bul; 2010 Oct; 44(4):579-84. PubMed ID: 21063970 [TBL] [Abstract][Full Text] [Related]
6. The prevalence of human T-lymphotropic virus infection among blood donors in southeast China, 2004-2013. Xie J; Ge S; Zhang Y; Lin Y; Ni H; Zhang J; Chen C PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003685. PubMed ID: 25830656 [TBL] [Abstract][Full Text] [Related]
7. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires]. Blejer JL; Saguier MC; Salamone HJ; Carreras LA Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226 [TBL] [Abstract][Full Text] [Related]
8. Seroprevalence and geographical distribution of human T-lymphotropic virus type 1 among volunteer blood donors in endemic areas of Iran. Karimi G; Zadsar M; Pourfathollah AA Virol J; 2017 Jan; 14(1):14. PubMed ID: 28137274 [TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of Human T-Cell Lymphotropic Virus-1/2 in Blood Donors in Northern Pakistan: Implications for Blood Donor Screening. Niazi SK; Bhatti FA; Salamat N J Coll Physicians Surg Pak; 2015 Dec; 25(12):874-7. PubMed ID: 26691361 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of human T-lymphotropic virus type 1 infection among blood donors in mainland China: a meta-analysis. Li X; Chen Y; Wu Z; Zhang N Int J Infect Dis; 2014 Aug; 25():94-9. PubMed ID: 24865322 [TBL] [Abstract][Full Text] [Related]
11. Human T-Lymphotropic Virus Type 1 and 2 Seroprevalence among first-time blood donors in Chile, 2011-2013. San Martín H; Balanda M; Vergara N; Valenzuela MA; Cartier L; Ayala S; Ramírez E J Med Virol; 2016 Jun; 88(6):1067-75. PubMed ID: 26538335 [TBL] [Abstract][Full Text] [Related]
12. Human T-cell lymphotropic virus testing of blood donors in Norway: a cost-effect model. Stigum H; Magnus P; Samdal HH; Nord E Int J Epidemiol; 2000 Dec; 29(6):1076-84. PubMed ID: 11101551 [TBL] [Abstract][Full Text] [Related]
13. Trend in seroprevalence of HTLV-1/2 in Taiwanese blood donors-A 10-year follow-up. Lee YH; Lu CT; Feng IJ; Hung CM Transfus Med; 2023 Aug; 33(4):320-328. PubMed ID: 37209036 [TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of HTLV-1 and HTLV-2 amongst mothers and children in Malawi within the context of a systematic review and meta-analysis of HTLV seroprevalence in Africa. Fox JM; Mutalima N; Molyneux E; Carpenter LM; Taylor GP; Bland M; Newton R; Martin F Trop Med Int Health; 2016 Mar; 21(3):312-24. PubMed ID: 26700941 [TBL] [Abstract][Full Text] [Related]
15. Saudi National Guard donor screening for human T cell lymphotropic virus I/II: time to use molecular biology techniques. Balkhy HH; Memish ZA; Abed E; Qasem L; Amer AB; Masoud S; Hajeer AH Mil Med; 2004 Mar; 169(3):251-3. PubMed ID: 15080248 [TBL] [Abstract][Full Text] [Related]
16. [Seroprevalence of HTLV-1/2 in blood donors from Misiones Province]. Malan R; Berini CA; Eirin ME; Delfino CM; Pedrozo W; Krupp R; García Plichta A; Biglione MM Medicina (B Aires); 2010; 70(1):71-4. PubMed ID: 20228028 [TBL] [Abstract][Full Text] [Related]
17. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil. Segurado AA; Malaque CM; Sumita LM; Pannuti CS; Lal RB Am J Trop Med Hyg; 1997 Aug; 57(2):142-8. PubMed ID: 9288805 [TBL] [Abstract][Full Text] [Related]
18. [Human T-lymphotropic virus type I (HTLV-I): risk of transmission with transfusion]. Lefrère JJ Presse Med; 2000 Jun; 29(20):1134-8. PubMed ID: 10901796 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of Human T-lymphotropic virus type 1 and 2 among blood donors in Manaus, Amazonas State, Brazil. Morais MPE; Gato CM; Maciel LA; Lalwani P; Costa CA; Lalwani JDB Rev Inst Med Trop Sao Paulo; 2017 Dec; 59():e80. PubMed ID: 29267588 [TBL] [Abstract][Full Text] [Related]
20. International forum: Saudi Arabia. Donor screening for HTLV-I in Saudi Arabia: is it cost effective? Bernvil SS; Andrews V; Coulter N Transfus Sci; 1997 Mar; 18(1):45-7. PubMed ID: 10174291 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]